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Bacterial skin infections, such as erysipelas or cellulitis, are characterized by fever and a painful erythematous
rash. Despite the high prevalence of these infections, little is known about the underlying pathogenic
mechanisms. This is partly due to the fact that a bacterial diagnosis is often difficult to attain. To gain insight into
the pathogenesis of erysipelas, we investigated the samples obtained from infected and noninfected areas of
skin from 12 patients with erysipelas. Bacterial cultures, detection of specific streptococcal antibodies in
convalescent sera, and immunohistochemical analyses of biopsies indicated group A streptococcal etiology in
11 of the 12 patients. Also, electron micrographs of erythematous skin confirmed the presence of group A
streptococcal cells and showed a limited solubilization of the surface-attached M protein. Degradation of high-
molecular-weight kininogen and upregulation of the bradykinin-1 receptor in inflamed tissues indicated
activation of the contact system in 11 patients. Analyses of release of the vasoactive heparin-binding protein
(HBP) showed increased levels in the infected as compared with the noninfected areas. The results suggest that
group A streptococci induce contact activation and HBP release during skin infection, which likely contribute to
the symptoms seen in erysipelas: fever, pain, erythema, and edema.
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INTRODUCTION
Erysipelas is a rapidly spreading infection of the superficial
layers of the skin often accompanied by systemic symptoms
such as fever, chills, and malaise. The progressing erythema
is characterized by a clear distinction from surrounding
tissue. Bacteriological diagnosis of the disease is often
difficult. Blood cultures are positive in o5% of cases (Perl
et al., 1999) and culturing of needle aspirations or punch
biopsies from skin lesions has limited value (Newell and
Norden, 1988; Duvanel et al., 1989; Lebre et al., 1996).
Cultures together with other available evidence such as
serological data indicate that the group A streptococcus is the
most prevalent pathogen, but other b-hemolytic streptococci
have also been implicated (Eriksson et al., 1996; Rantala
et al., 2009).
The human contact system (Bhoola et al., 1992; Colman
and Schmaier, 1997; Joseph and Kaplan, 2005) consists of
three serine proteinases: coagulation factor XI and XII, plasma
kallikrein, and the nonenzymatic cofactor high-molecular-
weight kininogen (HK). Activation of the contact system has
three potential consequences: the initiation of the intrinsic
pathway of coagulation, the generation of antibacterial
peptides, and the release of bradykinin, a proinflammatory
peptide that increases vascular permeability and induces
fever and pain. Bradykinin is generated when HK is cleaved by
activated plasma kallikrein into different protein fragments.
Previous studies have shown that several bacterial species,
such as Staphylococcus aureus, Escherichia coli, Salmonella,
and group A streptococci, can assemble components of the
contact system at their surface, resulting in bradykinin release
(Ben Nasr et al., 1996; Herwald et al., 1998; Mattsson et al.,
2001). In group A streptococci, HK is bound to the bacteria
by the cell-wall-attached M protein. When HK is associated
to the bacterial cell surface, it is exposed to a secreted
streptococcal cysteine proteinase (SpeB) that cleaves HK and
releases bradykinin both in vitro and in animal models of
infection (Herwald et al., 1996).
The M protein of group A streptococci has recently been
shown to interact with neutrophils by a previously unidenti-
fied mechanism. M proteins released from the streptococcal
cell wall form complexes with fibrinogen, which activate
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neutrophils by binding to b2 integrins (Herwald et al., 2004).
This leads to the secretion of the heparin-binding protein
(HBP), which is an inflammatory mediator that exert its effect
on the capillary endothelial cell layer and induces vascular
leakage (Gautam et al., 2001). It was shown that M protein,
when injected into mice, could induce severe pulmonary
damage characterized by leakage of plasma and blood cells
(Herwald et al., 2004; Soehnlein et al., 2008).
The skin lesion seen in patients with erysipelas has all the
characteristics of inflammation: an intense and painful
erythema with edematous elevation of the affected skin,
signs that could be explained, at least in part, by the action of
bradykinin and HBP released in response to group A
streptococcal infection. The aim of this investigation was
therefore to analyze whether the contact system and
neutrophils are activated in patients with erysipelas, and
thus help explain the pronounced local inflammation that is
characteristic of this disease.
RESULTS
Patient characteristics, bacterial cultures, and serologic testing
The 12 patients included in the study had typical signs of
erysipelas with fever and a characteristic erythema on one of
the legs. They were all admitted to hospital and treated with
antibiotics, and showed signs of recovery with absence of
fever and a less intense erythema within 3 days. A positive
blood culture for group A streptococci was found in one of
the patients (patient 11). Cultures were also taken from the
wound in four patients who had superficial skin wounds
present at the same leg as the erysipelas lesion. Two of these
patients were positive for group A streptococci, one for
S. aureus, and one patient had a mixed culture of both
S. aureus and group G streptococci (Table 1). Bacteriological
diagnosis by serologic testing was also carried out. IgG
antibody levels against seven different group A streptococcal
antigens, previously reported to evoke antibody responses
during group A streptococcal infections (A˚kesson et al.,
2004), were determined in acute and convalescent serum
samples. Seven of the twelve patients developed an increased
antibody titer, defined as a 450% increase of the ELISA
index, in the convalescence serum against at least two of the
streptococcal antigens (Table 1).
HK is degraded and HBP is released in the infected skin tissue
Activation of the contact system results in a proteolytic
cleavage of HK and the release of bradykinin. Bradykinin is a
small peptide that is cleared rapidly from tissue, and the
analysis of HK degradation is therefore a more reliable
measure of activation. Homogenized skin biopsies from
infected and noninfected areas were analyzed using western
blot. Antibodies against HK showed one 120 kDa band of the
same size as native HK in all samples, and one band of
63 kDa, which could correspond to either low molecular
weight kininogen or the heavy chain of HK (Figure 1). In the
material obtained from infected skin, additional immunor-
eactive bands were observed. Their molecular masses of 58
and 45 kDa correlate well to products observed after
cleavage of HK (Kahn et al., 2002), showing a degradation
of the protein (Figure 1a). In the controls taken from the
healthy tissue of the other leg, HK was degraded in only one
of the patient samples (Figure 1b).
The presence of HBP in the tissue samples was also
investigated. In another immunoblot of proteins extracted
from the biopsy specimens, antibodies against HBP detected
a band of the expected size of 29 kDa (Figure 2). HBP was
present in the skin tissue obtained from the infected area of
11 of the 12 patients, but only in one of the samples taken
from the healthy legs.
Inflammatory responses to group A streptococci in tissue
sections
Group A streptococci is regarded as the principal etiological
agent in erysipelas, but only seven patients could be
diagnosed with a group A streptococcal infection by culturing
or serologic testing. Tissue sections were therefore analyzed
by immunohistochemical staining using antibodies to
specific carbohydrate components of the group A strepto-
coccal cell wall. Also, sections were stained with antibodies
against the streptococcal SpeB, which is secreted from
all serotypes of group A streptococci. This assay revealed
the presence of group A streptococci in the tissue of 11 of the
12 patients (Table 2). The only patient whose tissue was
Table 1. Patient demographics and laboratory data of
patients with erysipelas
Patient Sex
Age
(years)
Prior
illness
Onset
days
(n)
Antibiotic
doses
(n)
Bacteriologic
culture
Serology
(GAS)
1 M 62 Diabetes 3 3 — 
2 F 50 Healthy 2 3 S. aureus 
3 F 77 Healthy 2 4 — +
4 M 61 Healthy 2 2 — +
5 M 63 Diabetes 1 2 — 
6 M 29 Healthy 2 3 GAS +
7 F 55 Healthy 3 3 — +
8 F 68 Diabetes 1 2 — 
9 F 88 Healthy 3 2 S. aureusþGGS 
10 M 50 Healthy 1 2 — +
11 F 85 Healthy 2 3 GAS +
12 F 58 Healthy 2 3 — +
Mean 62 2 2.5
Median 61.5 2 3
Range 29–88 1–3 2–4
Abbreviations: F, female; GAS, group A streptococci; GGS, group G
streptococci; M, male.
Onset days, number of days of disease prior to biopsy; antibiotic doses,
number of antibiotic doses before the time of biopsy; bacteriological
culture, bacteriological findings from blood and wound cultures; serology,
serology results from analysis of acute and convalescent sera against seven
different GAS antigens.
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negative for both group A streptococci and SpeB was culture
positive for S. aureus.
To further investigate the inflammatory responses triggered
by contact activation and the granular shedding of neutro-
phils, we stained the sections for the bradykinin-1 receptor
(BK-R1) and HBP. The expression of BK-R1 is induced by
IL-1b but also by bradykinin and its metabolites, and thus an
indicator of contact activation. Both BK-R1 and HBP were
present in all skin sections, however in varying amounts
when analyzed semiquantitatively (Table 2). A more detailed
analysis was performed in one of the patients (patient 11),
including analyses of two additional biopsies. One biopsy
was taken approximately 5 cm outside the margin of the
erythema and one biopsy from a corresponding region from
the other, noninfected leg. Staining intensities were higher for
all the studied antigens in the inflamed skin as compared with
the tissue adjacent to the infection or from the opposite leg
(Figure 3a). The biopsies were also stained for neutrophils,
which revealed a heavier infiltration of neutrophils in the
epicenter biopsy than in other sites (data not shown). Also, a
quantitation of antigen expression by acquired computerized
image analysis (ACIA) confirmed a considerably higher
prevalence of antigens in the erythematous area. However,
bacterial cell wall antigens and HBP were also detected in
tissue outside the apparent infection (Figure 3b). In addition,
analysis by confocal microscopy showed that group A
streptococcus were present in the epicenter of the erysipelas
infection (Figure 3c).
M protein is cleaved from the group A streptococcal surface
during skin infection
To visualize infecting bacteria at higher magnification, we
also analyzed tissue sections from three of the patients
(patients 1, 4, and 6) using transmission electron microscopy.
Figure 4a shows spherical cells in the dermis of the
erythematous skin of all patients. The structures are sugges-
tive of bacteria with a diameter of 0.6–1 mm. An experiment
with tissue sections from the same patients incubated with
gold-labeled antibodies against streptococcal cell wall
antigens, i.e., the group A carbohydrate, indicated that the
cells were indeed group A streptococci (Figure 4b). Com-
pared with previous electron micrographs of group A
streptococci grown in culture media (Fischetti, 1989;
Herwald et al., 2004), the bacteria identified in the
erythematous skin seemed to lack the hairlike structures
representing the surface-attached M proteins. Further
analyses showed that antibodies directed toward the cell-
wall-associated and -conserved C-terminal part of the
M1 protein bound to the bacteria (Figure 4c). The protruding
N-terminal part of the M proteins is highly variable among
group A streptococci of different serotypes. However, a
common property of these heterogeneous N-terminal
domains is the ability to bind fibrinogen. When skin sections
were incubated with gold-labeled human fibrinogen, no
colocalization was observed with bacterial surfaces
(Figure 4d). The results suggest that the N-terminal portion
of the M protein is cleaved off when group A streptococci
infect the skin.
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Figure 1. Proteolytic cleavage of HK in skin biopsies. Proteins were extracted
from skin biopsies from the leg with signs of inflammation (a) or of the other
noninfected leg (b) and subjected to SDS–PAGE. The gels were transferred to a
polyvinylidene difluoride membrane and probed with polyclonal antibodies
raised against high-molecular-weight kininogen (HK). Patients are numbered
1–12. Lanes marked ‘‘P’’ contain human plasma stimulated with dextran
sulfate, leading to degradation of intact HK.
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Figure 2. Presence of heparin-binding protein (HBP) in skin biopsies.
Extracted proteins from tissue taken from infected skin (a) or the contralateral
healthy-looking leg (b) of patients 1–12 were analyzed by immunoblotting
using a polyclonal antiserum against HBP. Lanes marked ‘‘H’’ contain
purified recombinant HBP.
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DISCUSSION
During acute inflammation, plasma components, and leuko-
cytes are transported to the infected tissue and interact to
defend against bacterial colonization, multiplication, and
dissemination. In this study, two different inflammatory
mechanisms during group A streptococcal infection were
studied: the triggering of the contact system and the release of
HBP from neutrophils.
Extensive proteolysis of HK was observed in all tissue
specimen obtained from the tender and erythematous skin of
the erysipelas infection. Also, the resulting HK fragments
were of the same molecular weight as shown in a previous
study showing contact activation in plasma during vasculitis
(Kahn et al., 2002). A heterogeneous degradation of the
65 kDa heavy chain of H kininogen was detected among the
patients. A possible explanation is varying activities in the
samples of other proteolytic enzymes known to degrade H
kininogen. For example, granulocyte elastase has been
shown to cleave H kininogen without destroying its
bradykinin portion (Kleniewski and Donaldson, 1988). The
local degradation of HK in infected skin is only an indirect
sign of bradykinin release, but the upregulation of BK-R1 in
the tissue sections strongly suggests the presence of brady-
kinin. It is known that HK can be activated on the surface of
endothelial cells (Colman and Schmaier, 1997), and that
bradykinin can be generated at the luminal side of the
endothelium (Reddigari et al., 1995). It has previously been
Table 2. Immunohistochemistry data of samples from
patients with erysipelas
Patient Site of biopsy GAS SpeB BK-R1 HBP
1 Epicenter ++ ++ + +
2 Epicenter 0 0 + +
3 Epicenter + + + +
4 Epicenter ++ ++ ++ ++
5 Epicenter (+) ++ + +
6 Epicenter ++ ++ + +
7 Epicenter ++ ++ ++ ++
8 Epicenter ++ ++ ++ ++
9 Epicenter + ++ + +
10 Epicenter + + + +
11 Epicenter ++ ++ ++ ++
5 cm distal + (+) + ++
Healthy leg (+) (+) (+) +
12 Epicenter ++ ++ + ++
Healthy leg + + + 0
Abbreviations: BK-R1, bradykinin receptor 1; GAS, group A streptococ-
cus; SpeB, streptococcal pyrogenic exotoxin B; HBP, heparin-binding
protein; 0, completely negative; (+), faint staining; +, few positive
cells or low expression of antigen; ++, high frequency of positive cells
or antigen.
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Figure 3. Host–pathogen responses at the local tissue site of infection. Tissue biopsies from the inflamed leg were obtained from the epicenter, 5 cm outside the
lesion, and from the healthy leg of patient 11. Biopsies were sectioned, stained for group A streptococci (GAS), streptococcal pyrogenic exotoxin B (SpeB),
bradykinin-1 receptor (BK-R1), heparin-binding protein (HBP), and analyzed by in situ imaging as described in Material and Methods. A control staining where
the primary antibody was omitted was also performed (ctrl). (a) Representative immunohistochemically stained areas, (b) acquired computerized image analysis
(ACIA) values of the whole tissue section. Group A streptococci were also identified by immunofluorescence staining and confocal microscopy analyses (c).
Note the distinct positively stained cocci indicated by arrows. Scale bars¼ 30mm (a) and 10mm (c).
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shown that plasma bradykinin levels are elevated in patients
with sepsis caused by S. aureus, and it has been speculated
that uncontrolled contact activation contributes to the
nonbeneficial inflammatory response seen in sepsis (Sriskan-
dan and Cohen, 2000; Mattsson et al., 2001). In this study,
contact activation was detected in the nonaffected leg in only
one patient, and in the patient sampled from an area just
outside the margin of erythema, the expression of BK-R1 was
markedly lower. This reflects a response that is limited and
localized to the area of bacterial invasion. The inflammatory
properties of bradykinin could be advantageous to the host by
causing pain and an influx of plasma component to the tissue
by increasing vascular permeability. Conversely, several
bacterial species secrete proteolytic enzymes that cleave
HK and generate bradykinin (Imamura et al., 2004), suggest-
ing that the physiological effects of bradykinin is favorable for
the bacterium under certain conditions.
Wound cultures and analyses of convalescent sera
revealed a likely group A streptococcal etiology in seven
out of the twelve patients. When tissues were analyzed using
immunohistochemistry and confocal microscopy, however,
group A streptococci were detected in all patients but
patient 2. This underlines the difficulties in obtaining a
bacterial diagnosis of clinical skin infections, but shows that
11 of 12 patients in this study were infected with group A
streptococci. Also, the data suggest that bacterial cells are
present throughout the inflamed skin area. This supports the
notion that inflammation is induced close to the bacterial
surfaces, and not only as a distant effect of streptococcal toxins.
Transmission electron microscopy also detected group A
streptococcal cells in the epidermis and dermis of the
infected skin. Antibody analyses of the sections showed that
the surface-attached M proteins of the bacteria had been
processed. M protein binds fibrinogen with high affinity
Patient  no.
1 4 6
Figure 4. Transmission electron microscopy of thin sections taken from the skin of three patients with erysipelas. (a) Spherical bacteria-like structures are
occasionally seen in the dermis. Sections were incubated with a specific antiserum against the Lancefield group A carbohydrate (b) or an antiserum raised
against the conserved C-terminal region of the M1 protein (c), followed by detection with gold-labeled secondary antibodies. Colocalization of group-A-specific
carbohydrate and M protein with bacterial cell surfaces is visible. (d) Sections were also incubated with gold-labeled fibrinogen. Scale bar¼ 0.5 mm.
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(Kantor, 1965), and this interaction has been mapped to the
variable N-terminal region of the M protein extending from
the bacterial surface (A˚kesson et al., 1994). It was previously
shown that when group A streptococci were incubated with
SpeB, fibrinogen-binding fragments of M protein were
solubilized (Berge and Bjo¨rck, 1995). The lack of colocaliza-
tion of fibrinogen to bacterial surfaces in the electron
micrographs suggests that biologically active M protein
fragments are released also during superficial skin infection.
As mentioned, circulating complexes of M protein and
fibrinogen are able to release neutrophil-derived HBP
(Herwald et al., 2004). The vascular leakage caused by
elevated levels of HBP is thought to be important in severe
streptococcal infections by inducing disturbed microcircula-
tion, hypotension, and organ failure. HBP has previously
been detected in tissue samples taken from patients with
group A streptococcal necrotizing fasciitis (Herwald et al.,
2004; Pa˚hlman et al., 2006). The local presence of HBP in
patients with erysipelas suggests the same mechanism also
during this milder condition. Severity of disease could thus be
related to differences in bacterial load, M protein expression,
or proteolytic activity.
A number of preclinical investigations have been performed
on the interactions between group A streptococci and the
contact system and neutrophils. This investigation has been an
attempt to study some of these mechanisms in a clinical setting
including patients with superficial skin infections. The partial
cleavage of the M protein from the bacterial surface, the
extensive degradation of HK and upregulation of BK-R1,
suggesting increased bradykinin levels, and the presence of
HBP in infected tissue, all fit into previously suggested
pathophysiological models. Finally, the study confirms that
the group A streptococcus is the predominant etiological agent
in spreading superficial infections of the skin.
MATERIALS AND METHODS
Patients, skin biopsies, and serum samples
Twelve patients presenting with erysipelas were enrolled in a
prospective nonconsecutive study at the Clinic for Infectious
Diseases, Lund University Hospital, Lund, Sweden, during
2004–2006. Skin biopsies were obtained from the patients after
informed written consent, according to protocols approved by the
ethics committee at Lund University and in accordance with the
Declaration of Helsinki Principles. The inclusion criteria were a
typical erythema localized on one of the lower extremities, and fever
438 1C. No patients with a history of recurrent erysipelas,
malignancies, radiation therapy, immunodeficiency, or immunosup-
pressive therapy were included. The median age of the patients was
61.5 years (range 29–88 years). The median time from the onset of
disease (erythema or fever) to inclusion was 2 days (range 1–3 days),
and all the patients had received antibiotic therapy before inclusion
(Table 1).
At the time of inclusion, two punch biopsy specimens (4 mm)
were obtained from the center of the lesion of each patient. One of
the biopsies was snap-frozen and stored at 80 1C and later
analyzed using protein extraction and western blot. The other
specimen was longitudinally cut in half and prepared for immuno-
histochemistry and electron microscopy. From each patient an
additional skin biopsy specimen was taken from the corresponding
area of the other noninfected leg, and from two of the patients
(patients 11 and 12) a third biopsy was taken from the affected leg at
a distance of 5 cm outside the advancing margin of the erythema.
These samples were stored frozen at 80 1C. Acute serum samples of
all patients were obtained at inclusion. Blood cultures and cultures
from skin wounds, when present at the same leg as the erythematous
lesion, were obtained before antibiotic therapy was started. Each
patient had a follow-up visit after 3–5 days and a final control after
27–75 days, when a convalescence serum sample was collected. No
recurrences were noted during this follow-up period.
ELISA
Antibody levels in patient sera against the extracellular group A
streptococcal proteins SpeB, SclB, MtsA, IdeS, and EndoS were
measured using an ELISA assay. The bacterial antigens and the
details of the assay were described previously (A˚kesson et al., 2004).
An antigen concentration of 0.5 mg ml1 was used for coating
microtiter plates (Maxisorp; Nunc, Rochester, NY). Antibodies
toward streptococcal DNAse and streptolysin were analyzed by
standard methods (enzyme inhibition test and latex agglutination
test, respectively) at the Department of Clinical Immunology, Lund
University Hospital.
Western blot
Skin samples of approximately 2 2 4 mm were homogenized by
mechanical disruption in 0.4 ml 10% SDS. After incubation at 99 1C
for 20 minutes, followed by centrifugation for 5 minutes at
3,000 r.p.m., the supernatants were collected. The protein content
in each supernatant was measured by optical density (Advanced
Protein Assay Reagent; Cytoskeleton, Denver, CO) and adjusted by
dilution in 10% SDS so that the total protein concentrations were
equal in all the samples. SDS sample buffer (10ml) was added to
supernatant (10ml) and incubated at 95 1C for 5 minutes. Proteins were
separated on a 4–12% NuPAGE Novex Bis-Tris gel (Invitrogen,
Carlsbad, CA), and transferred from the gel onto a polyvinylidene
difluoride membrane (Immobilon P, Millipore, Beillerca, MA) by
electrophoretic transfer according to the manufacturer’s instructions.
The membranes were blocked in phosphate-buffered saline with 5%
dry milk powder and 0.05% Tween 20. Presence of kininogens was
determined with antiserum AS88 (1:5,000 dilution; Mu¨ller-Esterl
et al., 1988). The second antibody was an anti-sheep IgG (1:3,000)
conjugated with horseradish peroxide (ICN Biomedicals, Costa Mesa,
CA). HBP was detected by a polyclonal anti-HBP rabbit antiserum
(1:5,000 dilution; Lindmark et al., 1999), and a horseradish-peroxide-
labeled anti-rabbit secondary antibody (Bio-Rad, Hercules, CA).
Immunoreactive protein bands were visualized with an electroche-
miluminescence kit (Pierce, Piscataway, NJ). As a positive control for
HK proteolysis, dextran sulfate (Sigma, St Louis, MO) was added to
human plasma. Plasma was incubated with dextran sulfate in the
presence of 2 mM zinc at a final concentration of 75mM at 37 1C for
1 hour. Recombinant HBP used as a control was produced and
purified as previously described (Rasmussen et al., 1996).
Immunohistochemical staining and confocal microscopy
Skin biopsies from patients were cryosectioned, fixed, stained,
and analyzed using image analysis as previously described
(Norrby-Teglund et al., 2001). Group A streptococci were identified
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using a polyclonal rabbit antiserum specific for the Lancefield group
A carbohydrate (Difco, Detroit, MI), and the in vivo expression of
SpeB was determined by a polyclonal rabbit antisera raised against
native SpeB (Toxin Technology, Sarasota, FL). HBP and BK-R1 were
identified by purified IgG from respective polyclonal anti-HBP and
anti-BK-R1 rabbit antiserum (Lindmark et al., 1999; Lamb et al.,
2002). The secondary antibody was a biotinylated goat anti-rabbit
IgG (Vector Laboratories, Burlingame, CA).
Immunohistochemical stainings were analyzed by ACIA. The
whole tissue section was included in the analysis, which yielded an
analyzed cell area (defined by the hematoxylin counterstaining)
ranging from 0.6 105 to 1.3 106 mm2. The results are presented as
ACIA value, which equals percent positively stained areamean
intensity of positive staining.
Immunofluorescence staining of group A streptococci was
performed and analyzed using confocal microscopy. The staining
procedure has previously been described in detail (Thulin et al.,
2006). Streptococci were identified using a specific rabbit antiserum
against the Lancefield group A carbohydrate. For evaluation, the
Leica (Wetzlar, Germany) confocal scanner TCS2 AOBS with an
inverted Leica DMIRE2 microscope was used.
Electron microscopy
Thin sections were subjected to immunolabeling as previously
described (Roth, 1986), except that Aurion-BSA (Aurion, Wageningen,
the Netherlands) was used as a blocking agent. Briefly, the sections
were placed on grids and incubated with a specific antiserum against
the Lancefield group A carbohydrate or a rabbit antiserum directed
against the conserved C-terminal part of the M1 protein (A˚kesson et al.,
1994), followed by immunodetection with 10 nm gold beads on a
secondary antibody against rabbit IgG (Agar Scientific, Stansted, UK).
Alternatively, specimens were incubated with human fibrinogen (Kabi)
coupled to colloidal gold before the final washing and fixation steps.
After further washes in incubation buffer, the sections were postfixed in
2% glutaraldehyde. Finally, sections were washed in distilled water,
poststained with uranyl acetate and lead citrate, and observed in a Jeol
(Tokyo, Japan) JEM 1230 transmission electron microscope, operated
at an accelerating voltage of 80 kV. Images were recorded with a
Gatan (Pleasanton, CA) MultiScan 791 CCD camera.
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